CEFPROZIL

N/A

Manufactured by Ascend Laboratories, LLC

2,368 FDA adverse event reports analyzed

Last updated: 2026-04-15

About CEFPROZIL

CEFPROZIL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Ascend Laboratories, LLC. The most commonly reported adverse reactions for CEFPROZIL include CHRONIC KIDNEY DISEASE, DRUG HYPERSENSITIVITY, COUGH, ACUTE KIDNEY INJURY, RASH. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CEFPROZIL.

Top Adverse Reactions

CHRONIC KIDNEY DISEASE89 reports
DRUG HYPERSENSITIVITY73 reports
COUGH61 reports
ACUTE KIDNEY INJURY59 reports
RASH57 reports
DYSPNOEA53 reports
PNEUMONIA53 reports
PYREXIA53 reports
RENAL FAILURE52 reports
FATIGUE50 reports
DIARRHOEA49 reports
URTICARIA49 reports
ARTHRALGIA43 reports
ABDOMINAL PAIN41 reports
DRUG INEFFECTIVE41 reports
VOMITING40 reports
OROPHARYNGEAL PAIN39 reports
OFF LABEL USE37 reports
NAUSEA34 reports
SINUSITIS34 reports
PRURITUS33 reports
PAIN31 reports
WHEEZING31 reports
ASTHMA30 reports
ERYTHEMA30 reports
HYPERSENSITIVITY30 reports
DIZZINESS26 reports
HEART RATE INCREASED26 reports
EAR INFECTION25 reports
MALAISE25 reports
NASOPHARYNGITIS25 reports
ANXIETY23 reports
UPPER RESPIRATORY TRACT INFECTION23 reports
BACK PAIN22 reports
COLITIS22 reports
HEADACHE22 reports
WEIGHT DECREASED22 reports
BLOOD PRESSURE INCREASED21 reports
CHOKING21 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION21 reports
URINARY TRACT INFECTION21 reports
BRONCHITIS20 reports
INFLUENZA20 reports
DIARRHOEA INFECTIOUS19 reports
END STAGE RENAL DISEASE19 reports
FALL19 reports
LUNG DISORDER19 reports
PRODUCT DOSE OMISSION ISSUE19 reports
WEIGHT INCREASED19 reports
DEPRESSION18 reports
NEPHROGENIC ANAEMIA18 reports
PRODUCTIVE COUGH18 reports
SPUTUM DISCOLOURED18 reports
ASTHENIA17 reports
MOUTH BREATHING17 reports
RHINITIS ALLERGIC17 reports
RHINORRHOEA17 reports
SNORING17 reports
CONDITION AGGRAVATED16 reports
PAIN IN EXTREMITY16 reports
PULMONARY EMBOLISM16 reports
CLOSTRIDIUM DIFFICILE COLITIS15 reports
DEATH15 reports
MUSCULOSKELETAL STIFFNESS15 reports
VIRAL INFECTION15 reports
OEDEMA PERIPHERAL14 reports
DEHYDRATION13 reports
DRUG INTOLERANCE13 reports
HYPOTENSION13 reports
PRODUCT USE IN UNAPPROVED INDICATION13 reports
RHEUMATOID ARTHRITIS13 reports
SECRETION DISCHARGE13 reports
SNEEZING13 reports
TUBULOINTERSTITIAL NEPHRITIS13 reports
CHEST DISCOMFORT12 reports
CHEST PAIN12 reports
GASTROOESOPHAGEAL REFLUX DISEASE12 reports
HOSPITALISATION12 reports
INFLUENZA LIKE ILLNESS12 reports
INJURY12 reports
MOBILITY DECREASED12 reports
REBOUND ACID HYPERSECRETION12 reports
RENAL INJURY12 reports
CYSTITIS11 reports
DRUG INTERACTION11 reports
EMOTIONAL DISTRESS11 reports
HEAT EXHAUSTION11 reports
INCORRECT DOSE ADMINISTERED11 reports
INSOMNIA11 reports
MUSCLE SPASMS11 reports
MUSCULAR WEAKNESS11 reports
NASAL CONGESTION11 reports
OVERWEIGHT11 reports
PNEUMONIA MYCOPLASMAL11 reports
PRODUCT AVAILABILITY ISSUE11 reports
RHINITIS11 reports
SEIZURE11 reports
SKIN DISCOLOURATION11 reports
WHITE BLOOD CELL COUNT DECREASED11 reports
DYSPNOEA EXERTIONAL10 reports

Report Outcomes

Out of 763 classified reports for CEFPROZIL:

Serious 79.6%Non-Serious 20.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female433 (63.3%)
Male248 (36.3%)
Unknown3 (0.4%)

Reports by Age

Age 4824 reports
Age 5219 reports
Age 4717 reports
Age 1015 reports
Age 1614 reports
Age 6914 reports
Age 513 reports
Age 5313 reports
Age 8012 reports
Age 3811 reports
Age 310 reports
Age 5810 reports
Age 5910 reports
Age 79 reports
Age 559 reports
Age 629 reports
Age 689 reports
Age 498 reports
Age 618 reports
Age 638 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CEFPROZIL?

This profile reflects 2,368 FDA FAERS reports that mention CEFPROZIL. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CEFPROZIL?

Frequently reported terms in FAERS include CHRONIC KIDNEY DISEASE, DRUG HYPERSENSITIVITY, COUGH, ACUTE KIDNEY INJURY, RASH, DYSPNOEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CEFPROZIL?

Labeling and FAERS entries often list Ascend Laboratories, LLC in connection with CEFPROZIL. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.